Saturday, March 26, 2022

< + > Pfizer Recalling 3 Blood Pressure Medication Types Due To Cancer Concerns, FDA Says

This time the culprit is a nitrosamine, N-nitroso-quinapril, being present in quantities above Acceptable Daily Intake (ADI) levels.

No comments:

Post a Comment

< + > Building the Healthcare AI Infrastructure Needed for the Next Era of Care

In a recent video interview with Healthcare IT Today, experts from two healthcare technology companies focus on the latest happenings with h...